课题基金 / 基金详情

Molecular design of nucleoside analogs for selective telomerase inhibition based on mechanisms of action.

Molecular design of nucleoside analogs for selective telomerase inhibition based on mechanisms of action.
基于作用机制的选择性端粒酶抑制核苷类似物的分子设计。
批准号:
14572102
负责人:
YAMAGUCHI Toyofumi
金额:
$1.79万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Molecular designing of nucleosides and corresponding 5'-triphosphates as potential selective inhibitor for telomerase has been considered ;We investigated the inhibitory effects of some sugar-modified nucleotide analogs on human telomerase. Among them, 3'-azido-2',3'-dideoxyguanosin (AZddG) 5'-triphosphate (AZddGTP), carbocyclic oxetanosin G triphosphate (c-oxtGTP) and some guanine-nucleotides showed more potent inhibitory activity against HeLa cell telomerase than that of thymine counterpart (AZTTP). AZddGTP seemed to be able to act as a chain terminator. AZddGTP did not show significant inhibitory activity against vertebrate DNA polymerase α and δ, suggesting that AZddGTP is a selective inhibitor telomerase. Next, we analyzed whether AZddG could alter telomere length and growth rates of human HL6O cells in culture. As the results, long-term treatment of AZddG caused reproducible telomere shortening, and a slight but steady decrease of cell growth rate. Thus, AZddG is an interesting potential telomerase inhibitor. Although telomere-shortening activity of AZddG was not potentiated when combined with arabinofuranosylcytosine (araC) in a preliminary experiment, further study of telomerase inhibitor as potentiators of conventional antitumor agents is now under way.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
Yamaguchi, Toyofumi: "Inhibition of vertebrate telomerases by the triphosphate derivatives of some biologically active nucleosides"Nucleosides Nucleotides Nucleic Acids. 22・5-8. 1575-1577 (2003)
Yamaguchi,Toyofumi:“某些生物活性核苷的三磷酸衍生物对脊椎动物端粒酶的抑制”核苷核酸 22·5-8(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Toyofumi Yamaguchi: "Inhibition of vertebrate telomerases by the triphosphate derivatives of some biologically active nucleosides"Nucleoside Nucleotides Nucleic Acids. 22(5-8). 1575-1577 (2003)
Toyofumi Yamaguchi:“某些生物活性核苷的三磷酸衍生物对脊椎动物端粒酶的抑制”核苷核苷酸核酸。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroshi Jinmei: "Telomerase-inhibitory effects of sugar-modified nucleotide analogs"Nucleic Acids Res. Supplement. 2. 221-222 (2002)
Hiroshi Jinmei:“糖修饰核苷酸类似物的端粒酶抑制作用”核酸研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Toyofumi Yamaguchi, Hazuki Takahashi, Hiroshi Jinmei, Yuko Takayama, Mineo Saneyoshi: "Inhibition of vertebrate telomerases by the triphosphate derivatives of some biologically active nucleosides"Nucleoside Nucleotides Nucleic Acids. 22(5-8). 1575-1577 (2
Toyofumi Yamaguchi、Hazuki Takahashi、Hiroshi Jinmei、Yuko Takayama、Mineo Saneyoshi:“某些生物活性核苷的三磷酸衍生物对脊椎动物端粒酶的抑制”核苷核苷酸核酸。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    国内基金
    海外基金
    SAGE1通过调控TERT转录促进肿瘤细胞增殖的机制研究
    • 批准号:
      32100582
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      葛云辉
    • 依托单位:
    HnRNP F/H在调控端粒酶活性、组装和转运中的作用和机制研究
    • 批准号:
      32070733
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      陈军
    • 依托单位:
    CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
    • 批准号:
      31900521
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      26.0万元
    • 批准年份:
      2019
    • 负责人:
      冯旭阳
    • 依托单位:
    CMSS1/RBM34/DDX5复合体调控端粒酶新机制的发现及其在非小细胞肺癌(NSCLC)发生发展中的作用机制
    • 批准号:
      31972889
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      颜廷东
    • 依托单位: